Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONSIDE
2023-509118-12-00Phase 2Authorised
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-bariatric hypoglycemia (PBH) comparing Sotagliflozin with Placebo (2 arms). Planned start Oct 2024; status: authorised.
02
Drugs
sotagliflozin
03
Conditions
post-bariatric hypoglycemia (PBH)
Beyond the preview
Go deeper on 2023-509118-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509118-12-00.